HF
NEXI

HRT Financial’s NexImmune, Inc. Common Stock NEXI Stock Holding History

HRT Financial’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,678
Closed -$11K – 3295
2023
Q2 		$11K Buy
+1,678
New +$14.5K ﹤0.01% 2165

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial's NEXI Position: Q3 2023 in Review

HRT Financial sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2023, closing a stake of 1,678 shares — an estimated $11K sold.

HRT Financial first reported a position in NEXI in Q2 2023 and held it in 1 quarter. The position peaked at $11K in Q2 2023. 30 funds tracked by Wall St. Rank hold NEXI as of Q3 2023.

  • HRT Financial reported no remaining NexImmune, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 1,678 NexImmune, Inc. Common Stock shares in Q3 2023, an estimated $11K.
  • HRT Financial first reported a position in NexImmune, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • HRT Financial's NexImmune, Inc. Common Stock position peaked at $11K in Q2 2023.
  • 30 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.